Brief: Eiger Biopharmaceuticals Provides Update On Status Of Planned Peginterferon Lambda Covid-19 Emergency Use Authorization Application

Eiger Biopharmaceuticals

06/09/2022 13:29

Sept 6 (Reuters) - Eiger BioPharmaceuticals Inc  EIGR.O :
    * EIGER BIOPHARMACEUTICALS PROVIDES UPDATE ON STATUS OF
PLANNED
PEGINTERFERON LAMBDA COVID-19 EMERGENCY USE AUTHORIZATION
APPLICATION
    * EIGER BIOPHARMA - FDA INDICATED IT IS NOT YET ABLE TO
DETERMINE
IF CRITERIA FOR SUBMISSION OF APPLICATION AND ISSUANCE OF AN EUA
ARE LIKELY TO BE MET
    * EIGER BIPPHARMA - FDA INDICATED WILL CONSIDER NEW
INFORMATION,
DATA FROM TOGETHER STUDY TO SUPPORT EUA, PLANS FOR FURTHER
DEVELOPMENT OF PEGINTERFERON LAMBDA
    * EIGER BIOPHARMACEUTICALS INC - IN ACTIVE DIALOGUE WITH FDA
    * EIGER BIOPHARMACEUTICALS INC - WORKING WITH "TOGETHER"
INVESTIGATORS ON PUBLICATION OF A MANUSCRIPT IN A PEER REVIEWED
JOURNAL

Source text for Eikon:  ID:nPn9p2TmHa 
Further company coverage:  EIGR.O 

 ((Reuters.Briefs@thomsonreuters.com;))